Overview
- 11 inspections across 11 sites are on record.
- 29 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-26.
At a glance
Inspections
11
Sites
11
Observations
29
Career since
Mar 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Newton Laboratories, Inc. | 26 Mar 2026 | Human Drugs | On file |
| Neogen Corporation | 6 Mar 2026 | Human Drugs | On file |
| American Regent, Inc. | 29 Jan 2026 | Human Drugs | On file |
| Smithfield Bioscience Inc | 23 Dec 2025 | Human Drugs | On file |
| Gojo Industries | 7 Nov 2025 | Human Drugs | On file |
Sites inspected
Newton Laboratories, Inc.Conyers, United States1 insp.
Neogen CorporationLexington, United States1 insp.
American Regent, Inc.New Albany, United States1 insp.
Smithfield Bioscience IncCincinnati, United States1 insp.
Gojo IndustriesWooster, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Rafeeq A Habeeb3 shared
Logan T Williams2 shared
John D Mcintosh1 shared
Nelson N Ayangho1 shared
JoshRenzo N Ramilo1 shared
Shannon L Maisano1 shared
Anna M Spiros1 shared
Joohi Castelvetere1 shared
Robert J Ham1 shared
Craig P Seaborn1 shared
Full investigator report
Get the verbatim findings behind Martin M Kimani's 29 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site